These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11779086

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
    Chun KS, Surh YJ.
    Biochem Pharmacol; 2004 Sep 15; 68(6):1089-100. PubMed ID: 15313405
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. COX-2 inhibition and prevention of cancer.
    Giercksky KE.
    Best Pract Res Clin Gastroenterol; 2001 Oct 15; 15(5):821-33. PubMed ID: 11566043
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K, Akay MT, Abbasoglu O, Ercan A.
    Cancer Detect Prev; 2004 Oct 15; 28(2):127-42. PubMed ID: 15068837
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL.
    Cancer Res; 2002 Feb 01; 62(3):625-31. PubMed ID: 11830509
    [Abstract] [Full Text] [Related]

  • 13. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
    Zeytin HE, Patel AC, Rogers CJ, Canter D, Hursting SD, Schlom J, Greiner JW.
    Cancer Res; 2004 May 15; 64(10):3668-78. PubMed ID: 15150127
    [Abstract] [Full Text] [Related]

  • 14. Pain management in osteoarthritis: the role of COX-2 inhibitors.
    Lane NE.
    J Rheumatol Suppl; 1997 Jul 15; 49():20-4. PubMed ID: 9249647
    [Abstract] [Full Text] [Related]

  • 15. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
    Sanborn R, Blanke CD.
    Semin Oncol; 2005 Feb 01; 32(1):69-75. PubMed ID: 15726508
    [Abstract] [Full Text] [Related]

  • 17. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
    Hochberg MC.
    Am J Manag Care; 2002 Nov 01; 8(17 Suppl):S502-17. PubMed ID: 12458820
    [Abstract] [Full Text] [Related]

  • 18. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
    Liao Z, Milas L, Komaki R, Stevens C, Cox JD.
    Am J Clin Oncol; 2003 Aug 01; 26(4):S85-91. PubMed ID: 12902863
    [Abstract] [Full Text] [Related]

  • 19. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
    Saha D, Pyo H, Choy H.
    Am J Clin Oncol; 2003 Aug 01; 26(4):S70-4. PubMed ID: 12902860
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
    Swamy MV, Herzog CR, Rao CV.
    Cancer Res; 2003 Sep 01; 63(17):5239-42. PubMed ID: 14500353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.